Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-04

Clinical Trial Update: PRO#0118: Decitabine Plus Mini Flu-Bu [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating decitabine with a mini Flu-Bu conditioning regimen for acute myeloid leukemia and myelodysplastic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUSULFAN (Busulfan)
  • Decitabine (Decitabine)
  • Fludarabine (Fludarabine)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: COMPLETED